Adjuvant immunotherapy of C6 glioma in rats with pertussis toxin
Purpose In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study was to determine the effect of pertussis toxin (PTx) as immunomodulatory molecule on glial tumors induced by C6 glioma cells. Methods Given...
Saved in:
Published in | Journal of cancer research and clinical oncology Vol. 138; no. 1; pp. 23 - 33 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer-Verlag
01.01.2012
Springer Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Purpose
In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study was to determine the effect of pertussis toxin (PTx) as immunomodulatory molecule on glial tumors induced by C6 glioma cells.
Methods
Given the pleiotropic effect of PTx on the immune system, we analyzed the effect of PTx on CD4+/CD25+/FoxP3+ (Treg) cells like as immunotherapeutic adjuvant. Thirty rats with a glial tumor of 1.5 cm in diameter were separated in two groups: the first group was treated with PTx and the second group was non-treated (controls). Tumoral volume was measured weekly; tumor, blood and spleen were taken for analysis of subpopulations of T cells, apoptotic index and cytokine contents, in both groups.
Results
We observed a significant decrease in tumor volume in the PTx group; this was associated with a decreased in the number of Treg cells, in both spleen and tumor. The percentage of apoptotic cells was increased as compared with that of controls. The production of proinflammatory cytokines was increased in mRNA for IL-6 as well as a small increase in the mRNA expression of perforin and granzime in tumors from rats treated with PTx. No changes were found in the mRNA expression of MCP-1 and MIP-1α.
Conclusion
These results suggest that PTx could be an immunotherapeutic adjuvant in the integral therapy against glial tumors. |
---|---|
AbstractList | In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study was to determine the effect of pertussis toxin (PTx) as immunomodulatory molecule on glial tumors induced by C6 glioma cells.
Given the pleiotropic effect of PTx on the immune system, we analyzed the effect of PTx on CD4+/CD25+/FoxP3+ (Treg) cells like as immunotherapeutic adjuvant. Thirty rats with a glial tumor of 1.5 cm in diameter were separated in two groups: the first group was treated with PTx and the second group was non-treated (controls). Tumoral volume was measured weekly; tumor, blood and spleen were taken for analysis of subpopulations of T cells, apoptotic index and cytokine contents, in both groups.
We observed a significant decrease in tumor volume in the PTx group; this was associated with a decreased in the number of Treg cells, in both spleen and tumor. The percentage of apoptotic cells was increased as compared with that of controls. The production of proinflammatory cytokines was increased in mRNA for IL-6 as well as a small increase in the mRNA expression of perforin and granzime in tumors from rats treated with PTx. No changes were found in the mRNA expression of MCP-1 and MIP-1α.
These results suggest that PTx could be an immunotherapeutic adjuvant in the integral therapy against glial tumors. Purpose: In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study was to determine the effect of pertussis toxin (PTx) as immunomodulatory molecule on glial tumors induced by C6 glioma cells. Methods: Given the pleiotropic effect of PTx on the immune system, we analyzed the effect of PTx on CD4+/CD25+/FoxP3+ (Treg) cells like as immunotherapeutic adjuvant. Thirty rats with a glial tumor of 1.5 cm in diameter were separated in two groups: the first group was treated with PTx and the second group was non-treated (controls). Tumoral volume was measured weekly; tumor, blood and spleen were taken for analysis of subpopulations of T cells, apoptotic index and cytokine contents, in both groups. Results: We observed a significant decrease in tumor volume in the PTx group; this was associated with a decreased in the number of Treg cells, in both spleen and tumor. The percentage of apoptotic cells was increased as compared with that of controls. The production of proinflammatory cytokines was increased in mRNA for IL-6 as well as a small increase in the mRNA expression of perforin and granzime in tumors from rats treated with PTx. No changes were found in the mRNA expression of MCP-1 and MIP-1 alpha . Conclusion: These results suggest that PTx could be an immunotherapeutic adjuvant in the integral therapy against glial tumors. In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study was to determine the effect of pertussis toxin (PTx) as immunomodulatory molecule on glial tumors induced by C6 glioma cells.PURPOSEIn spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study was to determine the effect of pertussis toxin (PTx) as immunomodulatory molecule on glial tumors induced by C6 glioma cells.Given the pleiotropic effect of PTx on the immune system, we analyzed the effect of PTx on CD4+/CD25+/FoxP3+ (Treg) cells like as immunotherapeutic adjuvant. Thirty rats with a glial tumor of 1.5 cm in diameter were separated in two groups: the first group was treated with PTx and the second group was non-treated (controls). Tumoral volume was measured weekly; tumor, blood and spleen were taken for analysis of subpopulations of T cells, apoptotic index and cytokine contents, in both groups.METHODSGiven the pleiotropic effect of PTx on the immune system, we analyzed the effect of PTx on CD4+/CD25+/FoxP3+ (Treg) cells like as immunotherapeutic adjuvant. Thirty rats with a glial tumor of 1.5 cm in diameter were separated in two groups: the first group was treated with PTx and the second group was non-treated (controls). Tumoral volume was measured weekly; tumor, blood and spleen were taken for analysis of subpopulations of T cells, apoptotic index and cytokine contents, in both groups.We observed a significant decrease in tumor volume in the PTx group; this was associated with a decreased in the number of Treg cells, in both spleen and tumor. The percentage of apoptotic cells was increased as compared with that of controls. The production of proinflammatory cytokines was increased in mRNA for IL-6 as well as a small increase in the mRNA expression of perforin and granzime in tumors from rats treated with PTx. No changes were found in the mRNA expression of MCP-1 and MIP-1α.RESULTSWe observed a significant decrease in tumor volume in the PTx group; this was associated with a decreased in the number of Treg cells, in both spleen and tumor. The percentage of apoptotic cells was increased as compared with that of controls. The production of proinflammatory cytokines was increased in mRNA for IL-6 as well as a small increase in the mRNA expression of perforin and granzime in tumors from rats treated with PTx. No changes were found in the mRNA expression of MCP-1 and MIP-1α.These results suggest that PTx could be an immunotherapeutic adjuvant in the integral therapy against glial tumors.CONCLUSIONThese results suggest that PTx could be an immunotherapeutic adjuvant in the integral therapy against glial tumors. In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study was to determine the effect of pertussis toxin (PTx) as immunomodulatory molecule on glial tumors induced by C6 glioma cells. Given the pleiotropic effect of PTx on the immune system, we analyzed the effect of PTx on CD4+/CD25+/FoxP3+ (Treg) cells like as immunotherapeutic adjuvant. Thirty rats with a glial tumor of 1.5 cm in diameter were separated in two groups: the first group was treated with PTx and the second group was non-treated (controls). Tumoral volume was measured weekly; tumor, blood and spleen were taken for analysis of subpopulations of T cells, apoptotic index and cytokine contents, in both groups. We observed a significant decrease in tumor volume in the PTx group; this was associated with a decreased in the number of Treg cells, in both spleen and tumor. The percentage of apoptotic cells was increased as compared with that of controls. The production of proinflammatory cytokines was increased in mRNA for IL-6 as well as a small increase in the mRNA expression of perforin and granzime in tumors from rats treated with PTx. No changes were found in the mRNA expression of MCP-1 and MIP-1α. These results suggest that PTx could be an immunotherapeutic adjuvant in the integral therapy against glial tumors.[PUBLICATION ABSTRACT] Purpose In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study was to determine the effect of pertussis toxin (PTx) as immunomodulatory molecule on glial tumors induced by C6 glioma cells. Methods Given the pleiotropic effect of PTx on the immune system, we analyzed the effect of PTx on CD4+/CD25+/FoxP3+ (Treg) cells like as immunotherapeutic adjuvant. Thirty rats with a glial tumor of 1.5 cm in diameter were separated in two groups: the first group was treated with PTx and the second group was non-treated (controls). Tumoral volume was measured weekly; tumor, blood and spleen were taken for analysis of subpopulations of T cells, apoptotic index and cytokine contents, in both groups. Results We observed a significant decrease in tumor volume in the PTx group; this was associated with a decreased in the number of Treg cells, in both spleen and tumor. The percentage of apoptotic cells was increased as compared with that of controls. The production of proinflammatory cytokines was increased in mRNA for IL-6 as well as a small increase in the mRNA expression of perforin and granzime in tumors from rats treated with PTx. No changes were found in the mRNA expression of MCP-1 and MIP-1α. Conclusion These results suggest that PTx could be an immunotherapeutic adjuvant in the integral therapy against glial tumors. |
Author | Sánchez-García, Francisco-Javier Hernández-Pedro, Norma Y. Sánchez-García, Aurora Guevara-Salazar, Patricia Sotelo, Julio Rangel-López, Edgar Orozco-Morales, Mario Pineda, Benjamín Perez-Madrigal, Rodolfo Arrieta, Oscar |
Author_xml | – sequence: 1 givenname: Mario surname: Orozco-Morales fullname: Orozco-Morales, Mario organization: Neuroimmunology Unit, Instituto Nacional de Neurologia y Neurocirugia (INNN), Immunoregulation Unit from Instituto Politecnico Nacional – sequence: 2 givenname: Francisco-Javier surname: Sánchez-García fullname: Sánchez-García, Francisco-Javier organization: Immunoregulation Unit from Instituto Politecnico Nacional – sequence: 3 givenname: Patricia surname: Guevara-Salazar fullname: Guevara-Salazar, Patricia organization: Neuroimmunology Unit, Instituto Nacional de Neurologia y Neurocirugia (INNN) – sequence: 4 givenname: Oscar surname: Arrieta fullname: Arrieta, Oscar organization: Laboratory of Experimental Oncology, Instituto Nacional de Cancerologia (INCan) – sequence: 5 givenname: Norma Y. surname: Hernández-Pedro fullname: Hernández-Pedro, Norma Y. organization: Laboratory of Experimental Oncology, Instituto Nacional de Cancerologia (INCan) – sequence: 6 givenname: Aurora surname: Sánchez-García fullname: Sánchez-García, Aurora organization: Pathology Unit, Instituto Nacional de Neurologia y Neurocirugia (INNN) – sequence: 7 givenname: Rodolfo surname: Perez-Madrigal fullname: Perez-Madrigal, Rodolfo organization: Neuroimmunology Unit, Instituto Nacional de Neurologia y Neurocirugia (INNN) – sequence: 8 givenname: Edgar surname: Rangel-López fullname: Rangel-López, Edgar organization: Neuroimmunology Unit, Instituto Nacional de Neurologia y Neurocirugia (INNN) – sequence: 9 givenname: Benjamín surname: Pineda fullname: Pineda, Benjamín email: benpio76@hotmail.com organization: Neuroimmunology Unit, Instituto Nacional de Neurologia y Neurocirugia (INNN) – sequence: 10 givenname: Julio surname: Sotelo fullname: Sotelo, Julio organization: Neuroimmunology Unit, Instituto Nacional de Neurologia y Neurocirugia (INNN) |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25566359$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21947268$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kktv1DAUhS1URKcDP4ANipAQbFL8drwq1YhHpUpsYG05jjPjUWIPtlOYf4-jmdKHRFeWfb9zdO71PQMnPngLwGsEzxGE4mOCkBJcQ4RqBLms98_AAs0viBB2AhYQCVQzjPgpOEtpC8udCfwCnGIkqcC8WYBPl912utE-V24cJx_yxka921ehr1a8Wg8ujLpyvoo6p-q3y5tqZ2OeUnKpyuGP8y_B814Pyb46nkvw88vnH6tv9fX3r1ery-vaMIJzjZgkrBVIGmgkNj0VpsWawV5L3beypawjvZWUc2uhNVBqIVjfNoIh0zUdJ0twcfDdTe1oO2N9jnpQu-hGHfcqaKceVrzbqHW4UQg1mJZ-i8P7o0MMvyabshpdMnYYtLdhSkoiQikXFBfyw5NkGX7TEEgxLOjbR-g2TNGXScx-SPCGkAK9uZ_9X-jbbyjAuyOgk9FDH7U3Lt1xjHFOygSXQBw4E0NK0fbKuKyzC3PLbijB5mxCHRZDlcVQ82KofVGiR8pb86c0-KBJhfVrG-96-7_oL9n2yiw |
CODEN | JCROD7 |
CitedBy_id | crossref_primary_10_1371_journal_pone_0168418 crossref_primary_10_1186_s40659_016_0067_6 crossref_primary_10_3390_toxins13080565 crossref_primary_10_1038_s41598_017_17752_w crossref_primary_10_1080_14760584_2017_1306440 crossref_primary_10_1515_revneuro_2023_0067 crossref_primary_10_1155_2013_716813 crossref_primary_10_18632_oncotarget_16214 crossref_primary_10_1155_2016_7487313 crossref_primary_10_1002_ijc_28858 crossref_primary_10_1007_s00432_013_1565_3 crossref_primary_10_2217_fmb_14_123 crossref_primary_10_3389_fmicb_2018_00783 |
Cites_doi | 10.1158/0008-5472.CAN-05-3773 10.3171/foc.2006.20.4.E1 10.1385/IR:32:1-3:155 10.1073/pnas.82.9.2637 10.1023/A:1006112422132 10.1038/nm1093 10.1126/science.161.3839.370 10.1111/j.1600-0897.2005.00330.x 10.1084/jem.182.2.581 10.1002/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1 10.1002/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO;2-W 10.1136/jcp.54.9.669 10.1007/s11060-006-9314-y 10.1002/jcp.10290 10.1084/jem.191.9.1605 10.1016/0008-8749(84)90228-4 10.3171/jns.2006.105.3.430 10.1016/S0959-8049(98)00244-5 10.1002/1521-4141(2000)30:8<2422::AID-IMMU2422>3.0.CO;2-H 10.1002/1521-4141(200211)32:11<3118::AID-IMMU3118>3.0.CO;2-B 10.1093/intimm/10.5.651 10.1056/NEJMoa043330 10.1215/15228517-2006-006 10.1016/S0165-5728(02)00203-5 10.1242/jcs.00378 10.1016/S0090-3019(99)00177-9 10.1084/jem.156.1.31 10.1002/eji.200535353 10.1007/s00262-005-0699-9 10.1046/j.1462-5822.2001.00106.x 10.1053/j.seminoncol.2003.11.031 10.1097/00005072-198709000-00001 10.1016/S0171-2985(11)80001-X 10.1161/ATVBAHA.107.159160 10.1128/IAI.59.12.4732-4734.1991 10.4049/jimmunol.177.3.1552 10.4049/jimmunol.170.4.1728 10.4049/jimmunol.178.10.6123 10.4049/jimmunol.130.6.2675 10.4049/jimmunol.169.1.117 10.4049/jimmunol.173.1.92 10.1007/s11060-004-3339-x 10.7785/tcrt.2012.500183 10.1007/BF00300234 10.5858/2003-127-187-CHCOTO 10.4049/jimmunol.163.10.5211 10.4049/jimmunol.170.3.1504 10.4049/jimmunol.169.5.2756 |
ContentType | Journal Article |
Copyright | Springer-Verlag 2011 2015 INIST-CNRS Springer-Verlag 2012 Springer-Verlag 2011 2011 |
Copyright_xml | – notice: Springer-Verlag 2011 – notice: 2015 INIST-CNRS – notice: Springer-Verlag 2012 – notice: Springer-Verlag 2011 2011 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7TO 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 K9. M0S M1P M2O MBDVC PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7T5 7X8 5PM |
DOI | 10.1007/s00432-011-1069-y |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Immunology Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts MEDLINE - Academic Research Library Prep |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1432-1335 |
EndPage | 33 |
ExternalDocumentID | PMC11824194 2550858641 21947268 25566359 10_1007_s00432_011_1069_y |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C -~X .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 1SB 2.D 203 28- 29K 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3V. 4.4 406 408 409 40D 40E 53G 5QI 5RE 5VS 67Z 6NX 78A 7X7 88E 8AO 8C1 8FI 8FJ 8G5 8UJ 95- 95. 95~ 96X AAAVM AABHQ AAHNG AAIAL AAJKR AAJSJ AAKKN AANXM AANZL AARHV AARTL AATVU AAUYE AAWCG AAYIU AAYOK AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABEEZ ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMOR ABMQK ABNWP ABPLI ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACACY ACBXY ACGFS ACHSB ACHVE ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACUDM ACULB ACZOJ ADBBV ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFFNX AFGXO AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BVXVI C24 C6C CAG CCPQU COF CS3 CSCUP D-I DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GROUPED_DOAJ GRRUI GUQSH GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M2O M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT5 Q2X QOK QOR QOS R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 X7M YLTOR Z45 Z7U Z82 Z83 Z87 Z8O Z8V Z8W Z91 ZGI ZMTXR ZOVNA ZXP ~EX ~KM AAFWJ AASML AAYXX ABDBE ABFSG ACSTC ADHKG AEZWR AFHIU AFPKN AGQPQ AHPBZ AHWEU AIXLP AYFIA CITATION PHGZM PHGZT IQODW PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7TO 7XB 8FK H94 K9. MBDVC PKEHL PQEST PQUKI PRINS Q9U RPM 7T5 7X8 5PM |
ID | FETCH-LOGICAL-c532t-15935b719c0c92cf47cb2a50fa9afb9b45d3fe9466ee0ec09a775fb8751cd8d63 |
IEDL.DBID | 7X7 |
ISSN | 0171-5216 1432-1335 |
IngestDate | Thu Aug 21 18:24:37 EDT 2025 Tue Aug 05 11:29:28 EDT 2025 Thu Jul 10 19:55:14 EDT 2025 Fri Aug 15 20:04:26 EDT 2025 Sun Jul 20 01:30:37 EDT 2025 Mon Jul 21 09:14:39 EDT 2025 Tue Jul 01 02:28:29 EDT 2025 Thu Apr 24 22:51:42 EDT 2025 Fri Feb 21 02:26:28 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | C6 glioma Regulatory T cells Glioblastoma multiforme Pertussis toxin Immunotherapeutic Nervous system diseases Rat Rodentia Adjuvant treatment Malignant tumor Malignant glioma Vertebrata Mammalia Animal Immunotherapy Central nervous system disease T-Lymphocyte Regulatory cell Cancer |
Language | English |
License | http://www.springer.com/tdm CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c532t-15935b719c0c92cf47cb2a50fa9afb9b45d3fe9466ee0ec09a775fb8751cd8d63 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/11824194 |
PMID | 21947268 |
PQID | 913176833 |
PQPubID | 47182 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11824194 proquest_miscellaneous_913446742 proquest_miscellaneous_1008830420 proquest_journals_913176833 pubmed_primary_21947268 pascalfrancis_primary_25566359 crossref_citationtrail_10_1007_s00432_011_1069_y crossref_primary_10_1007_s00432_011_1069_y springer_journals_10_1007_s00432_011_1069_y |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-01-01 |
PublicationDateYYYYMMDD | 2012-01-01 |
PublicationDate_xml | – month: 01 year: 2012 text: 2012-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Heidelberg – name: Germany |
PublicationTitle | Journal of cancer research and clinical oncology |
PublicationTitleAbbrev | J Cancer Res Clin Oncol |
PublicationTitleAlternate | J Cancer Res Clin Oncol |
PublicationYear | 2012 |
Publisher | Springer-Verlag Springer Springer Nature B.V |
Publisher_xml | – name: Springer-Verlag – name: Springer – name: Springer Nature B.V |
References | Tonon, Goriely, Aksoy, Pradier, Del Giudice, Trannoy, Willems, Goldman, De Wit (CR48) 2002; 32 Shimizu, Yamazaki, Sakaguchi (CR44) 1999; 163 Curiel, Coukos, Zou, Alvarez, Cheng, Mottram, Evdemon-Hogan, Conejo-Garcia, Zhang, Burow, Zhu, Wei, Kryczek, Daniel, Gordon, Myers, Lackner, Disis, Knutson, Chen, Zou (CR13) 2004; 10 Linthicum (CR32) 1982; 162 Ryan, McCarthy, Rappuoli, Mahon, Mills (CR43) 1998; 10 Garcia-Lora, Algarra, Garrido (CR21) 2003; 195 Linehan, Goedegebuure (CR31) 2005; 32 Darabi, Karulin, Boehm, Hofstetter, Fabry, LaManna, Chavez, Tary-Lehmann, Lehmann (CR15) 2004; 173 Onizuka, Tawara, Shimizu, Sakaguchi, Fujita, Nakayama (CR40) 1999; 59 Nencioni, Pizza, Volpini, De Magistris, Giovannoni, Rappuoli (CR39) 1991; 59 Buckner (CR8) 2003; 30 Hart, Linthicum, Waldschmidt, Tassell, Schelper, Robinson (CR24) 1987; 46 Liyanage, Moore, Joo, Tanaka, Herrmann, Doherty, Drebin, Strasberg, Eberlein, Goedegebuure, Linehan (CR34) 2002; 169 Linthicum, Frelinger (CR33) 1982; 156 Ichihara, Kono, Takahashi, Kawaida, Sugai, Fujii (CR28) 2003; 9 El Andaloussi, Lesniak (CR18) 2007; 83 Stupp, Mason, van den Bent, Weller, Fisher, Taphoorn, Belanger, Brandes, Marosi, Bogdahn, Curschmann, Janzer, Ludwin, Gorlia, Allgeier, Lacombe, Cairncross, Eisenhauer, Mirimanoff (CR47) 2005; 352 Agarwal, Sun, Su, Chan, Caspi (CR1) 2002; 129 Chen, Winkler-Pickett, Carbonetti, Ortaldo, Oppenheim, Howard (CR11) 2006; 36 Woo, Chu, Goletz, Schlienger, Yeh, Coukos, Rubin, Kaiser, June (CR50) 2001; 61 Chattopadhyay, Chakraborty, Mukherji (CR10) 2005; 54 Cassan, Piaggio, Zappulla, Mars, Couturier, Bucciarelli, Desbois, Bauer, Gonzalez-Dunia, Liblau (CR9) 2006; 177 Guevara, Sotelo (CR23) 1999; 44 Pineda, Estrada-Parra, Pedraza-Medina, Rodriguez-Ropon, Perez, Arrieta (CR42) 2005; 24 Zhu, Lu, Xiao, Qiao, Sun (CR53) 2005; 74 Backlund, Meade, Manclark, Cantoni, Aksamit (CR4) 1985; 82 Lopez-Gonzalez, Sotelo (CR35) 2000; 53 He, Gurunathan, Iwasaki, Ash-Shaheed, Kelsall (CR25) 2000; 191 Mielcarek, Hornquist, Johansson, Locht, Abraham, Holmgren (CR37) 2001; 3 Hou, Wu, Sun, Shi, Sun, Yang, Pei, Gu, Zhong, Sun (CR27) 2003; 170 Jager, Jager, Knuth (CR29) 2001; 54 Arrieta, Guevara, Reyes, Ortiz, Rembao, Sotelo (CR3) 1998; 34 Munoz, Bernard, Mackay (CR38) 1984; 83 Bruckener, el Baya, Galla, Schmidt (CR7) 2003; 116 Velasquez-Perez, Jimenez-Marcial (CR49) 2003; 127 Golgher, Jones, Powrie, Elliott, Gallimore (CR22) 2002; 32 Mascart, Verscheure, Malfroot, Hainaut, Pierard, Temerman, Peltier, Debrie, Levy, Del Giudice, Locht (CR36) 2003; 170 El Andaloussi, Han, Lesniak (CR19) 2006; 105 Shive, Hofstetter, Arredondo, Shaw, Forsthuber (CR45) 2000; 30 El Andaloussi, Lesniak (CR17) 2006; 8 Barnett, Kryczek, Cheng, Zou, Curiel (CR5) 2005; 54 Fecci, Mitchell, Whitesides, Xie, Friedman, Archer, Herndon, Bigner, Dranoff, Sampson (CR20) 2006; 66 Alt, Laschinger, Engelhardt (CR2) 2002; 32 Li, Liu, Zhang, Zhou, Guo, Chen, Ke, Jiang, Cai (CR52) 2011; 10 Tomayko, Reynolds (CR51) 1989; 24 Hofstetter, Shive, Forsthuber (CR26) 2002; 169 Strojnik, Kavalar, Zajc, Diamandis, Oikonomopoulou, Lah (CR46) 2009; 29 Cyster, Goodnow (CR14) 1995; 182 Chen, Howard, Oppenheim (CR12) 2007; 178 Kohno, Munoz, Williams, Teuscher, Bernard, Tung (CR30) 1983; 130 Benda, Lightbody, Sato, Levine, Sweet (CR6) 1968; 161 Papaspyridonos, McNeill, de Bono, Smith, Burnand, Channon, Greaves (CR41) 2008; 28 Deorah, Lynch, Sibenaller, Ryken (CR16) 2006; 20 EY Woo (1069_CR50) 2001; 61 D Golgher (1069_CR22) 2002; 32 MN Hart (1069_CR24) 1987; 46 MA Lopez-Gonzalez (1069_CR35) 2000; 53 R Stupp (1069_CR47) 2005; 352 JG Cyster (1069_CR14) 1995; 182 M Ryan (1069_CR43) 1998; 10 A El Andaloussi (1069_CR18) 2007; 83 B Pineda (1069_CR42) 2005; 24 L Nencioni (1069_CR39) 1991; 59 PS Backlund Jr (1069_CR4) 1985; 82 J He (1069_CR25) 2000; 191 K Darabi (1069_CR15) 2004; 173 P Guevara (1069_CR23) 1999; 44 KE Bruckener (1069_CR7) 2003; 116 F Ichihara (1069_CR28) 2003; 9 S Deorah (1069_CR16) 2006; 20 HH Hofstetter (1069_CR26) 2002; 169 W Hou (1069_CR27) 2003; 170 DS Linthicum (1069_CR33) 1982; 156 A El Andaloussi (1069_CR17) 2006; 8 DC Linehan (1069_CR31) 2005; 32 PE Fecci (1069_CR20) 2006; 66 C Alt (1069_CR2) 2002; 32 X Chen (1069_CR11) 2006; 36 T Strojnik (1069_CR46) 2009; 29 S Onizuka (1069_CR40) 1999; 59 C Cassan (1069_CR9) 2006; 177 B Barnett (1069_CR5) 2005; 54 X Chen (1069_CR12) 2007; 178 M Papaspyridonos (1069_CR41) 2008; 28 JC Buckner (1069_CR8) 2003; 30 S Chattopadhyay (1069_CR10) 2005; 54 1069_CR51 1069_CR52 1069_CR53 JJ Munoz (1069_CR38) 1984; 83 CL Shive (1069_CR45) 2000; 30 O Arrieta (1069_CR3) 1998; 34 UK Liyanage (1069_CR34) 2002; 169 S Kohno (1069_CR30) 1983; 130 DS Linthicum (1069_CR32) 1982; 162 L Velasquez-Perez (1069_CR49) 2003; 127 N Mielcarek (1069_CR37) 2001; 3 RK Agarwal (1069_CR1) 2002; 129 P Benda (1069_CR6) 1968; 161 F Mascart (1069_CR36) 2003; 170 D Jager (1069_CR29) 2001; 54 A El Andaloussi (1069_CR19) 2006; 105 J Shimizu (1069_CR44) 1999; 163 A Garcia-Lora (1069_CR21) 2003; 195 S Tonon (1069_CR48) 2002; 32 TJ Curiel (1069_CR13) 2004; 10 |
References_xml | – volume: 170 start-page: 1728 year: 2003 end-page: 1736 ident: CR27 article-title: Pertussis toxin enhances Th1 responses by stimulation of dendritic cells publication-title: J Immunol – volume: 66 start-page: 3294 year: 2006 end-page: 3302 ident: CR20 article-title: Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-3773 – volume: 163 start-page: 5211 year: 1999 end-page: 5218 ident: CR44 article-title: Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity publication-title: J Immunol – volume: 24 start-page: 575 year: 2005 end-page: 583 ident: CR42 article-title: Interstitial transfer factor as adjuvant immunotherapy for experimental glioma publication-title: J Exp Clin Cancer Res – volume: 20 start-page: E1 year: 2006 ident: CR16 article-title: Trends in brain cancer incidence, survival in the United States: Surveillance, Epidemiology, End Results Program, 1973 to 2001 publication-title: Neurosurg Focus doi: 10.3171/foc.2006.20.4.E1 – volume: 130 start-page: 2675 year: 1983 end-page: 2682 ident: CR30 article-title: Immunopathology of murine experimental allergic orchitis publication-title: J Immunol – volume: 32 start-page: 155 year: 2005 end-page: 168 ident: CR31 article-title: CD25+CD4+ regulatory T-cells in cancer publication-title: Immunol Res doi: 10.1385/IR:32:1-3:155 – volume: 82 start-page: 2637 year: 1985 end-page: 2641 ident: CR4 article-title: Pertussis toxin inhibition of chemotaxis and the ADP-ribosylation of a membrane protein in a human-mouse hybrid cell line publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.82.9.2637 – volume: 44 start-page: 91 year: 1999 end-page: 92 ident: CR23 article-title: C6 rat glioma grown into the peritoneal cavity, a large source of tumoral cells for subcutaneous transplant of glioma publication-title: J Neurooncol doi: 10.1023/A:1006112422132 – volume: 169 start-page: 117 year: 2002 end-page: 125 ident: CR26 article-title: Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund’s adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells publication-title: J Immunol – volume: 10 start-page: 942 year: 2004 end-page: 949 ident: CR13 article-title: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival publication-title: Nat Med doi: 10.1038/nm1093 – volume: 24 start-page: 148 year: 1989 end-page: 154 ident: CR51 article-title: Determination of subcutaneous tumor size in athymic (nude) mice publication-title: Cancer Chemother Pharmacol – volume: 59 start-page: 3128 year: 1999 end-page: 3133 ident: CR40 article-title: Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody publication-title: Cancer Res – volume: 161 start-page: 370 year: 1968 end-page: 371 ident: CR6 article-title: Differentiated rat glial cell strain in tissue culture publication-title: Science doi: 10.1126/science.161.3839.370 – volume: 170 start-page: 1504 year: 2003 end-page: 1509 ident: CR36 article-title: Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses publication-title: J Immunol – volume: 59 start-page: 4732 year: 1991 end-page: 4734 ident: CR39 article-title: Properties of the B oligomer of pertussis toxin publication-title: Infect Immun – volume: 54 start-page: 369 year: 2005 end-page: 377 ident: CR5 article-title: Regulatory T cells in ovarian cancer: biology and therapeutic potential publication-title: Am J Reprod Immunol doi: 10.1111/j.1600-0897.2005.00330.x – volume: 173 start-page: 92 year: 2004 end-page: 99 ident: CR15 article-title: The third signal in T cell-mediated autoimmune disease? publication-title: J Immunol – volume: 182 start-page: 581 year: 1995 end-page: 586 ident: CR14 article-title: Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords publication-title: J Exp Med doi: 10.1084/jem.182.2.581 – volume: 32 start-page: 3267 year: 2002 end-page: 3275 ident: CR22 article-title: Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens publication-title: Eur J Immunol doi: 10.1002/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1 – volume: 32 start-page: 2133 year: 2002 end-page: 2144 ident: CR2 article-title: Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis publication-title: Eur J Immunol doi: 10.1002/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO;2-W – volume: 54 start-page: 669 year: 2001 end-page: 674 ident: CR29 article-title: Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer publication-title: J Clin Pathol doi: 10.1136/jcp.54.9.669 – volume: 9 start-page: 4404 year: 2003 end-page: 4408 ident: CR28 article-title: Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers publication-title: Clin Cancer Res – volume: 83 start-page: 145 year: 2007 end-page: 152 ident: CR18 article-title: CD4+CD25+FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas publication-title: J Neurooncol doi: 10.1007/s11060-006-9314-y – volume: 195 start-page: 346 year: 2003 end-page: 355 ident: CR21 article-title: MHC class I antigens, immune surveillance, and tumor immune escape publication-title: J Cell Physiol doi: 10.1002/jcp.10290 – volume: 178 start-page: 6123 year: 2007 end-page: 6129 ident: CR12 article-title: Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells publication-title: J Immunol – volume: 191 start-page: 1605 year: 2000 end-page: 1610 ident: CR25 article-title: Primary role for Gi protein signaling in the regulation of interleukin 12 production and the induction of T helper cell type 1 responses publication-title: J Exp Med doi: 10.1084/jem.191.9.1605 – volume: 83 start-page: 92 year: 1984 end-page: 100 ident: CR38 article-title: Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen publication-title: Cell Immunol doi: 10.1016/0008-8749(84)90228-4 – volume: 105 start-page: 430 year: 2006 end-page: 437 ident: CR19 article-title: Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors publication-title: J Neurosurg doi: 10.3171/jns.2006.105.3.430 – volume: 34 start-page: 2101 year: 1998 end-page: 2106 ident: CR3 article-title: Protamine inhibits angiogenesis and growth of C6 rat glioma; a synergistic effect when combined with carmustine publication-title: Eur J Cancer doi: 10.1016/S0959-8049(98)00244-5 – volume: 177 start-page: 1552 year: 2006 end-page: 1560 ident: CR9 article-title: Pertussis toxin reduces the number of splenic Foxp3+ regulatory T cells publication-title: J Immunol – volume: 10 start-page: 95 year: 2011 end-page: 100 ident: CR52 article-title: Cellular immunologic response to primary cryoablation of C6 gliomas in rats publication-title: Technol Cancer Res Treat – volume: 30 start-page: 2422 year: 2000 end-page: 2431 ident: CR45 article-title: The enhanced antigen-specific production of cytokines induced by pertussis toxin is due to clonal expansion of T cells and not to altered effector functions of long-term memory cells publication-title: Eur J Immunol doi: 10.1002/1521-4141(2000)30:8<2422::AID-IMMU2422>3.0.CO;2-H – volume: 32 start-page: 3118 year: 2002 end-page: 3125 ident: CR48 article-title: Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns publication-title: Eur J Immunol doi: 10.1002/1521-4141(200211)32:11<3118::AID-IMMU3118>3.0.CO;2-B – volume: 61 start-page: 4766 year: 2001 end-page: 4772 ident: CR50 article-title: Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer publication-title: Cancer Res – volume: 29 start-page: 3269 year: 2009 end-page: 3279 ident: CR46 article-title: Prognostic impact of CD68 and kallikrein 6 in human glioma publication-title: Anticancer Res – volume: 10 start-page: 651 year: 1998 end-page: 662 ident: CR43 article-title: Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7–1, B7–2 and CD28 publication-title: Int Immunol doi: 10.1093/intimm/10.5.651 – volume: 352 start-page: 987 year: 2005 end-page: 996 ident: CR47 article-title: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma publication-title: N Engl J Med doi: 10.1056/NEJMoa043330 – volume: 8 start-page: 234 year: 2006 end-page: 243 ident: CR17 article-title: An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme publication-title: Neuro Oncol doi: 10.1215/15228517-2006-006 – volume: 129 start-page: 133 year: 2002 end-page: 140 ident: CR1 article-title: Pertussis toxin alters the innate and the adaptive immune responses in a pertussis-dependent model of autoimmunity publication-title: J Neuroimmunol doi: 10.1016/S0165-5728(02)00203-5 – volume: 74 start-page: 9 year: 2005 end-page: 17 ident: CR53 article-title: An experimental study of dendritic cells mediated immunotherapy against intracranial gliomas in rats publication-title: J Neurooncol – volume: 116 start-page: 1837 year: 2003 end-page: 1846 ident: CR7 article-title: Permeabilization in a cerebral endothelial barrier model by pertussis toxin involves the PKC effector pathway and is abolished by elevated levels of cAMP publication-title: J Cell Sci doi: 10.1242/jcs.00378 – volume: 53 start-page: 157 year: 2000 end-page: 162 ident: CR35 article-title: Brain tumors in Mexico: characteristics and prognosis of glioblastoma publication-title: Surg Neurol doi: 10.1016/S0090-3019(99)00177-9 – volume: 156 start-page: 31 year: 1982 end-page: 40 ident: CR33 article-title: Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes publication-title: J Exp Med doi: 10.1084/jem.156.1.31 – volume: 169 start-page: 2756 year: 2002 end-page: 2761 ident: CR34 article-title: Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma publication-title: J Immunol – volume: 36 start-page: 671 year: 2006 end-page: 680 ident: CR11 article-title: Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells publication-title: Eur J Immunol doi: 10.1002/eji.200535353 – volume: 54 start-page: 1153 year: 2005 end-page: 1161 ident: CR10 article-title: Regulatory T cells and tumor immunity publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-005-0699-9 – volume: 3 start-page: 181 year: 2001 end-page: 188 ident: CR37 article-title: Interaction of Bordetella pertussis with mast cells, modulation of cytokine secretion by pertussis toxin publication-title: Cell Microbiol doi: 10.1046/j.1462-5822.2001.00106.x – volume: 30 start-page: 10 year: 2003 end-page: 14 ident: CR8 article-title: Factors influencing survival in high-grade gliomas publication-title: Semin Oncol doi: 10.1053/j.seminoncol.2003.11.031 – volume: 127 start-page: 187 year: 2003 end-page: 192 ident: CR49 article-title: Clinical-histopathologic concordance of tumors of the nervous system at the Manuel Velasco Suarez National Institute of Neurology and Neurosurgery in Mexico City publication-title: Arch Pathol Lab Med – volume: 46 start-page: 511 year: 1987 end-page: 521 ident: CR24 article-title: Experimental autoimmune inflammatory myopathy publication-title: J Neuropathol Exp Neurol doi: 10.1097/00005072-198709000-00001 – volume: 162 start-page: 211 year: 1982 end-page: 220 ident: CR32 article-title: Development of acute autoimmune encephalomyelitis in mice: factors regulating the effector phase of the disease publication-title: Immunobiology doi: 10.1016/S0171-2985(11)80001-X – volume: 28 start-page: 433 year: 2008 end-page: 440 ident: CR41 article-title: Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.107.159160 – volume: 44 start-page: 91 year: 1999 ident: 1069_CR23 publication-title: J Neurooncol doi: 10.1023/A:1006112422132 – volume: 129 start-page: 133 year: 2002 ident: 1069_CR1 publication-title: J Neuroimmunol doi: 10.1016/S0165-5728(02)00203-5 – volume: 59 start-page: 4732 year: 1991 ident: 1069_CR39 publication-title: Infect Immun doi: 10.1128/IAI.59.12.4732-4734.1991 – volume: 53 start-page: 157 year: 2000 ident: 1069_CR35 publication-title: Surg Neurol doi: 10.1016/S0090-3019(99)00177-9 – volume: 177 start-page: 1552 year: 2006 ident: 1069_CR9 publication-title: J Immunol doi: 10.4049/jimmunol.177.3.1552 – volume: 162 start-page: 211 year: 1982 ident: 1069_CR32 publication-title: Immunobiology doi: 10.1016/S0171-2985(11)80001-X – volume: 170 start-page: 1728 year: 2003 ident: 1069_CR27 publication-title: J Immunol doi: 10.4049/jimmunol.170.4.1728 – volume: 10 start-page: 651 year: 1998 ident: 1069_CR43 publication-title: Int Immunol doi: 10.1093/intimm/10.5.651 – volume: 178 start-page: 6123 year: 2007 ident: 1069_CR12 publication-title: J Immunol doi: 10.4049/jimmunol.178.10.6123 – volume: 20 start-page: E1 year: 2006 ident: 1069_CR16 publication-title: Neurosurg Focus doi: 10.3171/foc.2006.20.4.E1 – volume: 352 start-page: 987 year: 2005 ident: 1069_CR47 publication-title: N Engl J Med doi: 10.1056/NEJMoa043330 – volume: 34 start-page: 2101 year: 1998 ident: 1069_CR3 publication-title: Eur J Cancer doi: 10.1016/S0959-8049(98)00244-5 – volume: 83 start-page: 92 year: 1984 ident: 1069_CR38 publication-title: Cell Immunol doi: 10.1016/0008-8749(84)90228-4 – volume: 28 start-page: 433 year: 2008 ident: 1069_CR41 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.107.159160 – volume: 156 start-page: 31 year: 1982 ident: 1069_CR33 publication-title: J Exp Med doi: 10.1084/jem.156.1.31 – volume: 30 start-page: 10 year: 2003 ident: 1069_CR8 publication-title: Semin Oncol doi: 10.1053/j.seminoncol.2003.11.031 – volume: 191 start-page: 1605 year: 2000 ident: 1069_CR25 publication-title: J Exp Med doi: 10.1084/jem.191.9.1605 – volume: 130 start-page: 2675 year: 1983 ident: 1069_CR30 publication-title: J Immunol doi: 10.4049/jimmunol.130.6.2675 – volume: 3 start-page: 181 year: 2001 ident: 1069_CR37 publication-title: Cell Microbiol doi: 10.1046/j.1462-5822.2001.00106.x – volume: 30 start-page: 2422 year: 2000 ident: 1069_CR45 publication-title: Eur J Immunol doi: 10.1002/1521-4141(2000)30:8<2422::AID-IMMU2422>3.0.CO;2-H – volume: 169 start-page: 117 year: 2002 ident: 1069_CR26 publication-title: J Immunol doi: 10.4049/jimmunol.169.1.117 – volume: 46 start-page: 511 year: 1987 ident: 1069_CR24 publication-title: J Neuropathol Exp Neurol doi: 10.1097/00005072-198709000-00001 – volume: 54 start-page: 1153 year: 2005 ident: 1069_CR10 publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-005-0699-9 – volume: 173 start-page: 92 year: 2004 ident: 1069_CR15 publication-title: J Immunol doi: 10.4049/jimmunol.173.1.92 – volume: 24 start-page: 575 year: 2005 ident: 1069_CR42 publication-title: J Exp Clin Cancer Res – volume: 54 start-page: 369 year: 2005 ident: 1069_CR5 publication-title: Am J Reprod Immunol doi: 10.1111/j.1600-0897.2005.00330.x – volume: 32 start-page: 155 year: 2005 ident: 1069_CR31 publication-title: Immunol Res doi: 10.1385/IR:32:1-3:155 – volume: 83 start-page: 145 year: 2007 ident: 1069_CR18 publication-title: J Neurooncol doi: 10.1007/s11060-006-9314-y – volume: 54 start-page: 669 year: 2001 ident: 1069_CR29 publication-title: J Clin Pathol doi: 10.1136/jcp.54.9.669 – volume: 32 start-page: 3118 year: 2002 ident: 1069_CR48 publication-title: Eur J Immunol doi: 10.1002/1521-4141(200211)32:11<3118::AID-IMMU3118>3.0.CO;2-B – volume: 116 start-page: 1837 year: 2003 ident: 1069_CR7 publication-title: J Cell Sci doi: 10.1242/jcs.00378 – volume: 32 start-page: 2133 year: 2002 ident: 1069_CR2 publication-title: Eur J Immunol doi: 10.1002/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO;2-W – volume: 32 start-page: 3267 year: 2002 ident: 1069_CR22 publication-title: Eur J Immunol doi: 10.1002/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1 – ident: 1069_CR53 doi: 10.1007/s11060-004-3339-x – volume: 82 start-page: 2637 year: 1985 ident: 1069_CR4 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.82.9.2637 – volume: 182 start-page: 581 year: 1995 ident: 1069_CR14 publication-title: J Exp Med doi: 10.1084/jem.182.2.581 – volume: 61 start-page: 4766 year: 2001 ident: 1069_CR50 publication-title: Cancer Res – volume: 10 start-page: 942 year: 2004 ident: 1069_CR13 publication-title: Nat Med doi: 10.1038/nm1093 – ident: 1069_CR52 doi: 10.7785/tcrt.2012.500183 – volume: 59 start-page: 3128 year: 1999 ident: 1069_CR40 publication-title: Cancer Res – ident: 1069_CR51 doi: 10.1007/BF00300234 – volume: 127 start-page: 187 year: 2003 ident: 1069_CR49 publication-title: Arch Pathol Lab Med doi: 10.5858/2003-127-187-CHCOTO – volume: 105 start-page: 430 year: 2006 ident: 1069_CR19 publication-title: J Neurosurg doi: 10.3171/jns.2006.105.3.430 – volume: 36 start-page: 671 year: 2006 ident: 1069_CR11 publication-title: Eur J Immunol doi: 10.1002/eji.200535353 – volume: 195 start-page: 346 year: 2003 ident: 1069_CR21 publication-title: J Cell Physiol doi: 10.1002/jcp.10290 – volume: 8 start-page: 234 year: 2006 ident: 1069_CR17 publication-title: Neuro Oncol doi: 10.1215/15228517-2006-006 – volume: 163 start-page: 5211 year: 1999 ident: 1069_CR44 publication-title: J Immunol doi: 10.4049/jimmunol.163.10.5211 – volume: 66 start-page: 3294 year: 2006 ident: 1069_CR20 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-3773 – volume: 170 start-page: 1504 year: 2003 ident: 1069_CR36 publication-title: J Immunol doi: 10.4049/jimmunol.170.3.1504 – volume: 161 start-page: 370 year: 1968 ident: 1069_CR6 publication-title: Science doi: 10.1126/science.161.3839.370 – volume: 29 start-page: 3269 year: 2009 ident: 1069_CR46 publication-title: Anticancer Res – volume: 9 start-page: 4404 year: 2003 ident: 1069_CR28 publication-title: Clin Cancer Res – volume: 169 start-page: 2756 year: 2002 ident: 1069_CR34 publication-title: J Immunol doi: 10.4049/jimmunol.169.5.2756 |
SSID | ssj0017572 |
Score | 2.0517185 |
Snippet | Purpose
In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study... In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this study was to... Purpose: In spite of the recent advances in surgery and antitumor drugs, the brain tumors, like glioblastoma, have shown a poor prognosis. The aim of this... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 23 |
SubjectTerms | Adjuvants Animals Antineoplastic agents Apoptosis Apoptosis - drug effects Apoptosis - immunology Biological and medical sciences Blood Brain cancer Cancer Research CD25 antigen CD4 antigen CD4-Positive T-Lymphocytes - drug effects CD4-Positive T-Lymphocytes - immunology Chemokine CCL3 - biosynthesis Chemokine CCL3 - genetics Chemokine CCL3 - immunology Cytokines Female Foxp3 protein Gene expression Glioblastoma Glioma - drug therapy Glioma - immunology Glioma - pathology Glioma cells Granzymes - biosynthesis Granzymes - genetics Granzymes - immunology Hematology Immune system Immunologic Factors - immunology Immunologic Factors - pharmacology Immunomodulation Immunosuppressive agents Immunotherapy Inflammation Interleukin 6 Interleukin-2 Receptor alpha Subunit - immunology Interleukin-6 - biosynthesis Interleukin-6 - genetics Interleukin-6 - immunology Internal Medicine Lymphocytes T macrophage inflammatory protein 1 Macrophages - drug effects Macrophages - immunology Medical sciences Medicine Medicine & Public Health Monocyte chemoattractant protein 1 Neurology Oncology Original Paper Perforin Perforin - biosynthesis Perforin - genetics Perforin - immunology pertussis toxin Pertussis Toxin - immunology Pertussis Toxin - pharmacology Pharmacology. Drug treatments Prognosis Rats Rats, Wistar Real-Time Polymerase Chain Reaction RNA, Messenger - biosynthesis RNA, Messenger - genetics Rodents Spleen Surgery T-Lymphocytes, Regulatory - drug effects T-Lymphocytes, Regulatory - immunology Tumors of the nervous system. Phacomatoses |
SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bi9UwEB50BRFEvFtXlwg-KYUmbXN587C4LML65IF9K7lqZbc9bHvA8--d9LYc3RV8TtKEmaT5JjPzDcB7KT2iABdS3D5ooHi0UxR3LKWW0qCddyLEBOezr_x0XXw5L8-nPO5ujnafXZLDn3pJdhvY49IxBIurdHcX7pVousc4rjVbLa4DUQ4VmyIPDFpZlM-uzJs-sXcZPdzoDuUSxoIWNyHOvwMn__CeDpfSyWN4NKFJshrV_wTu-OYp3D-b_OXP4NPK_dwiVu5JHfNApmyrHWkDOebk-0XdXmpSNwS3QUfikyzZ-Kt-i-ekI337q26ew_rk87fj03SqmZDaMmd9iugkL42gymZWMRsKYQ3TZRa00sEoU5QuDz6SynufeZspLUQZDFot1DrpeP4CDpq28a-ACBPNMR-kdb4QQRnKuMlcZrWzZVAqgWwWXmUnQvFY1-KiWqiQB3lXKO8qyrvaJfBhGbIZ2TT-1floTyPLiMiahjgJF3A4q6iaTl5XKYqIiMs8T-Dd0opHJvpBdOPbbRenkzI-42QJkFv6xICEWIiFJfBy1Pn19FQVgnGZgNzbDUuHyNi939LUPwbm7mjNFTg8gY_zxrle-a2CeP1fvQ_hAYI6Nj4TvYGD_mrr3yJw6s3RcFB-AyggEWE priority: 102 providerName: Springer Nature |
Title | Adjuvant immunotherapy of C6 glioma in rats with pertussis toxin |
URI | https://link.springer.com/article/10.1007/s00432-011-1069-y https://www.ncbi.nlm.nih.gov/pubmed/21947268 https://www.proquest.com/docview/913176833 https://www.proquest.com/docview/1008830420 https://www.proquest.com/docview/913446742 https://pubmed.ncbi.nlm.nih.gov/PMC11824194 |
Volume | 138 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3ra9RAEB-0BRGK1Gdj22MFPynBbJ67n_R6XC1Ki4gH56eQ7EMjNTmbHHj_vTN5lVPbLwlkd9nN7OzuvPY3AC-FMCgFaOsi-6CCYlBPkbH2Xa44t5k2OrF0wfn8Ij5bhB-W0bKPzan7sMphT2w3al0pspG_kRxPulgEwdvVL5eSRpFztc-gcRd2CbmMmDpZjvoWHoxt7iZChEF9i8eDU9PrMEQDikmgeK5YuputY2lvldVIIdultvif7PlvCOVfftT2eDrdhwe9XMmmHSM8hDumfAT3znvP-WN4N9U_1ig1N6ygGyH9vasNqyybxezbZVH9zFhRMmSImpFxlq3MVbPGFVOzpvpdlE9gcTr_Mjtz--wJrooCv3FRTgmiPOFSeUr6yoaJyv0s8mwmM5vLPIx0YA3ByxvjGeXJLEkim6P-wpUWOg6ewk5ZleYAWJKTYmasUNqEiZU59-Pc057KtIqslA54A_FS1UOLU4aLy3QERW7pnSK9U6J3unHg1dhk1eFq3FZ5sjUjYwvCT0OJCQdwOExR2q_BOh05xoEXYykuHvKIZKWp1jV1JwQZdDwH2A11KDSBUrL4Djzr5vy6ey7DxI-FA2KLG8YKhN29XVIW31sMb9LrQmzuwOuBca5HfiMhnt_6n4dwH8U5vzMQHcFOc7U2xygyNfmkXRj4FDM-gd3p-68f5_g-mV98-oxfF_70D0P8GO4 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9RADLZKkaASQpwlFMogwQsoYjI55wFBtVBtabdPrdS3kMwBQSVZmqxgfxT_ETtXtUD71ufM5PAR22P7M8CLJDHoBWjrovhggGIwTpGRFq6nPM9m2ujYUoPz7DCaHgefTsKTNfg99MJQWeXwT2x_1LpSdEb-Rnpo6aLE99_Nf7g0NIqSq8MEjU4q9s3yJ0Zs9du9D8jel0LsfjyaTN1-qICrQl80LppvP8xjTyqupFA2iFUuspDbTGY2l3kQat8aQl03hhvFZRbHoc3RrfeUTnTk432vwfXAR82kxvTJWFGChridFUUINBjfedGQROUdZqlPNRBUPxZJd7liBm_Nsxo5YrtRGv_zdf8t2fwrb9uaw907cLv3Y9lOJ3h3Yc2U9-DGrM_U34f3O_rbAr30hhXUgdL3eS1ZZdkkYl9Oi-p7xoqSoQDWjA6D2dycNQvU0Jo11a-ifADHV0LYh7BeVqV5BCzOKRA0NlHaBLGVuSeinGuuMq1CK6UDfCBeqnooc5qocZqOIMwtvVOkd0r0TpcOvBq3zDscj8sWb69wZNxBeG3ooeELbA0sSnudr9NRQh14Pl5FZaUMTFaaalHT45KEDpC4A-yCNVQKQSNghAObHc_PH-_JIBZR4kCyIg3jAsIKX71SFl9bzHCKIwPc7sDrQXDO3_xCQjy-9Dufwc3p0ewgPdg73N-CDXQlRXc49QTWm7OFeYruWpNvt0rC4PNVa-UfHXFRwQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bT9VAEJ4gJsSEGK9QUVwTfdE0tNvb7oNRcvAERIgPkvBW271oDbZH2hM9P81_50xv5KjwxvPuttu5dGZ2Zr8BeC6EQS9AWxfFBwMUg3GKjDV3feX7NtNGJ5YuOB8dx_sn4fvT6HQFfg93Yaiscvgntj9qXSk6I9-RPlq6WATBju2rIj7uTd_MfrjUQIoSrUM3jU5CDs3iJ0Zv9euDPWT1C86n7z5N9t2-wYCrooA3LpryIMoTXypPSa5smKicZ5FnM5nZXOZhpANrCIHdGM8oT2ZJEtkcXXxfaaHjAJ97A24mQSJIxcRkrC5Bo9z2jSI0Goz1_HhIqHodfmlA9RBUSxZLd7FkEtdnWY3csV1bjf_5vf-Wb_6Vw21N4_QO3O59WrbbCeFdWDHlPVg76rP29-Htrv42R4-9YQXdRunvfC1YZdkkZl_Oiup7xoqSoTDWjA6G2cycN3PU1po11a-ifAAn10LYh7BaVqXZBJbkFBQaK5Q2YWJl7vM497SnMq0iK6UD3kC8VPWw5tRd4ywdAZlbeqdI75TonS4ceDkumXWYHldN3l7iyLiCsNvQW8MNbA0sSnv9r9NRWh14No6i4lI2JitNNa_pdULQYZLnALtkDpVFUDsY7sBGx_OL1_syTHgsHBBL0jBOINzw5ZGy-Nrih1NMGeJyB14NgnOx80sJ8ejK73wKa6iP6YeD48MtuIVeJe_OqR7DanM-N0_Qc2vy7VZHGHy-bqX8A9-ZVfc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adjuvant+immunotherapy+of+C6+glioma+in+rats+with+pertussis+toxin&rft.jtitle=Journal+of+cancer+research+and+clinical+oncology&rft.au=OROZCO-MORALES%2C+Mario&rft.au=SANCHEZ-GARCIA%2C+Francisco-Javier&rft.au=GUEVARA-SALAZAR%2C+Patricia&rft.au=ARRIETA%2C+Oscar&rft.date=2012-01-01&rft.pub=Springer&rft.issn=0171-5216&rft.volume=138&rft.issue=1&rft.spage=23&rft.epage=33&rft_id=info:doi/10.1007%2Fs00432-011-1069-y&rft.externalDBID=n%2Fa&rft.externalDocID=25566359 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0171-5216&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0171-5216&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0171-5216&client=summon |